HL7.TERMINOLOGY\SubstanceAdminSubstitutionNotAllowedReason

This page is part of the HL7 Terminology (v2.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

ValueSet: SubstanceAdminSubstitutionNotAllowedReason

Summary

Defining URL:

http://terminology.hl7.org/ValueSet/v3-SubstanceAdminSubstitutionNotAllowedReason

Version:

2.0.0

Name:

SubstanceAdminSubstitutionNotAllowedReason

Status:

Active as of 2014-03-26

Definition:

Reasons why substitution of a substance administration request is not permitted.

OID:

2.16.840.1.113883.1.11.19719 (for OID based terminology systems)

Source Resource:

XML / JSON / Turtle

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

This value set includes codes based on the following rules:

Include these codes as defined in http://terminology.hl7.org/CodeSystem/v3-ActReason
Code Display Definition
PAT Patient request The Patient requested the action
Include codes from http://terminology.hl7.org/CodeSystem/v3-ActReason where concept is-a _SubstanceAdminSubstitutionNotAllowedReason

Expansion

This value set contains 5 concepts

Expansion based on ActReason v2.0.0 (CodeSystem)

All codes from system http://terminology.hl7.org/CodeSystem/v3-ActReason

Code	Display	Definition
PAT	Patient request	The Patient requested the action
_SubstanceAdminSubstitutionNotAllowedReason	SubstanceAdminSubstitutionNotAllowedReason	Reasons why substitution of a substance administration request is not permitted.
ALGINT	allergy intolerance	Definition: Patient has had a prior allergic intolerance response to alternate product or one of its components.
COMPCON	compliance concern	Definition: Patient has compliance issues with medication such as differing appearance, flavor, size, shape or consistency.
THERCHAR	therapeutic characteristics	The prescribed product has specific clinical release or other therapeutic characteristics not shared by other substitutable medications.
TRIAL	clinical trial drug	Definition: The specific manufactured drug is part of a clinical trial.

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code

History

Date

Action

Author

Custodian

Comment

2020-05-06

revise